Marked transaminase elevations and worsening glycemic control associated with counterfeit polyherbal use in a patient with diabetes

Journal of Pharmacy Practice

Volumn 22, Issue 6, 2009, Pages 600-605

  Henyan, Nickole N ^a   Riche, Daniel M ^b   Pitcock, James J ^b   Strickland, Dayna C ^c  

^a Shore Health System   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diabetes; Herbal; Hoodia gordonii; Transaminases

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FEXOFENADINE; HEMOGLOBIN A1C; HERBACEOUS AGENT; ILLICIT DRUG; LISINOPRIL; METFORMIN; ROSIGLITAZONE; ROSUVASTATIN;

ADULT; ARTICLE; CASE REPORT; CAUCASIAN; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HOODIA GORDONII; HUMAN; LIVER TOXICITY; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; WEIGHT REDUCTION;

EID: 77949400232     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190009341257     Document Type: Article

References (17)

1. Anderson RN, Smith BL. Deaths: leading causes for 2002. Natl Vital Stat Rep. 2005;53(17):1-89.
2. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229-234.
3. Bays HE. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res. 2004;12(8):1197-1211.
4. McBride BF, Karapanos AK, Krudysz A, et al. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA. 2004; 291(2):216-221.
5. Sultan S, Spector J, Mitchell RM. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement. Mayo Clin Proc. 2006;81(12): 1630-1631.
6. Avula B, Wang YH, Pawar RS, et al. Determination of the appetite suppressant P57 in Hoodia gordonii plant extracts and dietary supplements by liquid chromatography/electrospray ionization mass spectrometry (LC-MSD-TOF) and LC-UV methods. J AOAC Int. 2006;89(3):606-611.
7. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol Ther. 1981;30(2):239-245.
8. FDA Warns Consumers about Counterfeit Drugs from Multiple Internet Sellers. http://www.fda.gov/bbstopics/NEWS/2007/NEW01623.html. Accessed March 4, 2008.
9. National Institutes of Health National Center for Complementary and Alternative Medicine. http://nccam.nih.gov. Accessed January 6, 2007.
10. Jellin JM, Gregory PJ, Batz F, et al. Pharmacist's Letter/ Prescriber's Letter Natural Medicines Comprehensive Database. 4th ed. Stockton, CA: Therapeutic Research Faculty; 2002.
11. Taylor AV, Wise PH. Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgrad Med J. 1998;74(872):365-366.
12. Harbison RM. Hamilton and Hardy's Industrial Toxicology. 5th ed. St. Louis, MO: Mosby; 1998.
13. Molinari M, Watt KDS, Kruszyna T, et al. Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl. 2006;12(12): 1892-1895.
14. Lukaszkiewicz J, Proszynska K, Lorenc R. Hepatic microsomal enzyme induction: treatment of vitamin D poisoning in a 7 month old baby (letter). Br Med J. 1987;295(6607):1173.
15. Vial T, Bernard G, Lewden B, et al. Acute hepatitis due to Exolise, a Camellia sinis-dervied drug. Gastroenterol Clin Biol. 2003;27(12):1166-1167.
16. Peyrin-Biroulet L, Petitpain N, Kalt P, et al. Probable hepatotoxicity from epigalocatecol gallate used for phytotherapy. Gastroenterol Clin Biol. 2004;28(4): 404-406.
17. Abu el Wafa Y, Benaventa Fernandez A, Talavera Fabuel A, et al. Acute hepatitis induced by Camellia sinensis (green tea). An Med Interna. 2005;22(6):298.